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Introduction
It has been widely established that the actin-binding protein 
dystrophin is critical for muscle membrane cytoskeletal integ-
rity. Loss-of-function mutations in dystrophin results in the   
X-linked catastrophic muscle-wasting disorder Duchenne’s muscle 
dystrophy (DMD). Dystrophin is localized to the sarcolemma 
in  skeletal muscles, where it associates with multiple trans-
membrane proteins, which include dystroglycan, to form the 
large membrane-spanning specialized adhesion complex known   
as the dystrophin protein complex (DPC; Hoffman et al., 1987; 
Koenig et al., 1988; Zubrzycka-Gaarn et al., 1988; Ervasti and 
Campbell, 1991; Ibraghimov-Beskrovnaya et al., 1992). Dys-
trophin binds F-actin inside the cell. Through extracellular 
interactions with laminin by dystroglycan, the DPC connects 
the muscle actin cytoskeleton to the ECM and, as such, is hypoth-
esized to provide mechanical protection against the physical 
stresses of repetitive muscle contractions. Interruption of this 
linkage results in impaired membrane integrity and degenera-
tion of muscle tissue (Mokri and Engel, 1975; Deconinck and 
Dan, 2007; Ervasti, 2007). Mutations in other DPC components, 
such as the sarcoglycans, also result in progressive muscle   
dystrophies, highlighting the importance of the DPC in main-
taining muscle membrane integrity (Sandonà and Betto, 2009). 
Interestingly, a significant number of DMD patients also exhibit 
cognitive  deficits,  the  underlying  pathology  of  which  is  not 
clear (Bresolin et al., 1994; Mehler, 2000; Wicksell et al., 2004). 
The prevalence of neural defects accompanying many dystro-
phin mutations suggests a wider role for dystrophin in humans, 
thus underscoring the importance of identifying their functions 
in the nervous system.
Like muscles, the nervous system is also subjected to me-
chanical forces exerted externally as well as within the organ-
ism itself. Neuronal circuitries established during development 
must withstand the physical stresses of brain growth and synap-
tic activity-dependent neuronal remodeling as well as the me-
chanical impacts of body movements and environmental insults 
(Bénard and Hobert, 2009). Adhesion protein complexes are 
known  to  participate  in  maintaining  neural  integrity  against 
these physical forces. For example, impaired N-cadherin func-
tion causes defects in maintaining the positions of neurons in 
zebrafish (Lele et al., 2002; Masai et al., 2003). The identification 
of molecules that participate in maintaining neural architecture 
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(Brenman et al., 1996; Hasegawa et al., 1999; Lumeng et al., 
1999; Adams et al., 2001; Gavillet et al., 2006; Hirn et al., 
2008).  Consistent  with  STN-2/-syntrophin  functioning  to-
gether with DYS-1/dystrophin, stn-2(tm1869) mutant animals 
exhibit similar abnormal movements with exaggerated head 
bending (Fig. 1), which was previously described for dys-1  
mutant animals (Bessou et al., 1998). Indeed, dys-1 and stn-2 
mutant animals show the characteristic head bend (Fig. 1 A), 
and they move with a reduced number of body bends per minute 
as compared with wild-type animals (Fig. 1 B). As a putative 
DPC  component,  we  hypothesized  that  STN-2/-syntrophin 
may link SAX-7 to the DPC and that this association may be 
important for SAX-7 function. To test this hypothesis, we as-
sayed whether DYS-1/dystrophin participates in the positional 
maintenance of neurons (see Materials and methods). Analysis 
of dys-1 mutant animals revealed displaced cholinergic neurons 
in >20% of dys-1(cx18) and dys-1(cx40) adult animals (Fig. 2). 
Displacement of the affected neurons, which are embryonically 
derived (Sulston et al., 1983), is less prevalent in younger dys-1 
animals and is first detected in a small proportion of L3-staged 
larvae and an increasing proportion of L4-staged larvae (Fig. 2 C). 
This apparent progressive displacement is similarly observed in 
sax-7 mutant animals (Wang et al., 2005) and is consistent with 
a role for dys-1 in maintaining the position of neurons.
To further investigate a role for dys-1 in neuronal position 
maintenance, we assessed whether dys-1(cx18) or dys-1(cx40) 
genetically interacts with sax-7. Genetic or pharmacological 
suppression of movements in sax-7 animals was previously shown 
to suppress the neuronal displacement phenotype (Sasakura   
et al., 2005; Pocock et al., 2008). Thus, in these genetic assays, 
we intentionally used dys-1/+ heterozygosity to circumvent the 
possibility that the prolonged muscle excitation displayed by 
dys-1 homozygous animals (Bessou et al., 1998; Kim et al., 
2004, 2009) may nonspecifically enhance neuronal displace-
ment in sax-7 mutant backgrounds. Moreover, because homo-
zygous  sax-7(eq1)-null  animals  exhibit  >95%  penetrance  of 
displaced neurons (Fig. 2, D and E; Wang et al., 2005), we as-
sessed the consequences of dys-1/+ heterozygosity on neuronal 
displacement in sax-7(eq1)/+ animals. Displaced cholinergic and 
-aminobutyric acid (GABA) neurons located along the ventral 
nerve cord (VNC) were observed in 10% dys-1/+;sax-7(eq1)/+ 
trans-heterozygous animals, whereas neuronal displacement 
was not detected in either dys-1/+ or sax-7(eq1)/+ single hetero-
zygous mutant animals (Fig. 2, D and E). This genetic inter-
action  between  dys-1  and  sax-7  is  significant  and  is  also 
illustrated by an enhancement of displaced neurons by dys-1/+ 
in  animals  that  are  homozygous  for  the  hypomorphic  sax-7  
allele eq2 (Wang et al., 2005). Indeed, displaced cholinergic neu-
rons were detected in 37% of dys-1/+;sax-7(eq2) as compared 
with 4% of sax-7(eq2) single mutant animals (Fig. 2 D). The 
penetrance of GABA neuron displacement is also increased in 
dys-1/+;sax-7(eq2) animals as compared with sax-7(eq2) single 
mutant animals (Fig. 2 E). Collectively, these results reveal a 
role for dys-1 in maintaining neuron positions.
Aging dys-1 animals are reported to exhibit some muscle 
degeneration, particularly in a sensitized hlh-1 mutant background 
(Gieseler et al., 2000; Grisoni et al., 2003). Thus, it is possible that 
has  been  relatively  successful  in  Caenorhabditis  elegans  
because of the simplicity of its nervous system and the ease of 
performing genetic manipulations. One protein that is required 
to maintain the C. elegans neural organization is SAX-7, a 
homologue of the L1 family of cell adhesion molecules (CAMs; 
Bénard and Hobert, 2009; Chen and Zhou, 2010).
Vertebrate L1CAMs, which include L1, neuronal CAM 
(NrCAM), neurofascin, and CHL1, are known to function in 
nervous  system  development  and  function  (Hortsch,  2003). 
Mutations in human NrCAM can result in autism, whereas im-
paired L1 function causes several different X-linked neural   
disorders, which include corpus callosum hyperplasia, mental 
retardation, adducted thumbs, spastic paraplegia, and hydro-
cephalus (Rosenthal et al., 1992; Van Camp et al., 1993; Jouet 
et al., 1994; Fransen et al., 1995; Marui et al., 2009). As trans-
membrane proteins, L1CAMs have been shown to form cell–
cell and cell–ECM adhesion via diverse extracellular interactions 
as well as associate with the membrane actin cytoskeleton by 
binding cytoskeletal linkers, such as ankyrin. This cytoskeletal 
anchorage  via  ankyrin  has  been  shown  to  be  important  for 
L1CAM function (Needham et al., 2001; Buhusi et al., 2008). 
Ankyrin interaction is similarly important for SAX-7 function 
(Zhou et al., 2008). Additional binding sites to cytoskeletal   
linkers that are conserved in L1CAM cytoplasmic tails also 
contribute to SAX-7 function, underscoring the importance of 
cytoskeletal anchorage to L1CAMs. One of these sites, a PDZ 
(PSD95, Dlg, Zo1)-binding (PB) motif, was shown to mediate 
interaction with STN-2/-syntrophin (Zhou et al., 2008), a pu-
tative component of the DPC. This finding raises the possibility 
for dystrophin to function in conjunction with L1CAMs in the 
nervous system.
In this study, we present genetic data that the sole C. ele-
gans dystrophin gene, dys-1, plays a role in maintaining neural 
organization. This novel role, which requires dys-1 function in 
neurons, is distinguishable from its requirement in body-wall 
muscle to maintain muscle integrity and regulate membrane   
excitability for proper locomotion (Bessou et al., 1998; Gieseler 
et al., 2000). We provide biochemical data that SAX-7 asso-
ciates  with  DYS-1/dystrophin  in  an  STN-2/-syntrophin– 
dependent fashion. Linkage to DYS-1/dystrophin likely provides 
SAX-7 anchorage to the actin cytoskeleton, thereby regulating 
SAX-7–mediated cell adhesions. This study provides insight 
into the common molecular mechanisms that may underlie di-
verse cognitive conditions, particularly those of the DMD and 
L1CAM disorders.
Results
dys-1 participates in positional 
maintenance of neurons
We previously identified STN-2/-syntrophin as a SAX-7 inter-
actor that regulates SAX-7 activity in maintaining placement of 
neurons and their axons (Zhou et al., 2008). Although the role 
of STN-2/-syntrophin has not been characterized, mammalian 
syntrophins are known components of the DPC that link di-
verse cytoplasmic and membrane proteins, including signaling   
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maintenance of the VNC cholinergic and GABA neurons (Wang 
et al., 2005). dys-1 is predominantly expressed in the VNC neu-
rons as well as body-wall and vulval muscles, as determined by 
Pdys-1::gfp transcriptional reporters (Bessou et al., 1998; Dupuy 
et al., 2007; Hunt-Newbury et al., 2007). To determine the site 
of function for dys-1, we assayed for rescue of the displaced 
neuron phenotype in dys-1 animals expressing full-length DYS-1/
dystrophin in either neurons or muscles using tissue-specific 
promoters. Only DYS-1/dystrophin expressed in neurons rescued 
the neuronal displacement phenotype in dys-1 homozygous and 
dys-1/+;sax-7/+ animals (Fig. 3). Similarly, only neuronally ex-
pressed DYS-1/dystrophin suppressed the genetic enhancement 
displayed  in  dys-1/+;sax-7(eq2)  animals,  whereas  DYS-1/ 
dystrophin expressed in body-wall muscles did not (Fig. 3).
DYS-1/dystrophin expressed in body-wall muscles did, 
however,  rescue  the  abnormal  movement  and  head-bending 
phenotype, which is characteristic of dys-1 animals (Fig. 1),   
dys-1/+ in a sensitized sax-7 background could result in muscle 
degeneration or abnormal muscle morphology, which may indi-
rectly cause altered positioning of the adjacent VNC neurons and 
tissues along the ventral midline. Immunostaining of -integrin 
and phalloidin staining of actin did not reveal the presence of 
muscle degeneration or obvious defects in muscle morphology 
and sarcomeric organization in young adult dys-1 or sax-7  
animals  or  in  dys-1/+  animals  in  sax-7  mutant  backgrounds   
(Fig. S1). Furthermore, young adult dys-1 or sax-7 animals do not 
exhibit vulval displacement (Fig. S2), suggesting that this posi-
tional maintenance role for dys-1 and sax-7 is specific for neurons.
dys-1 and stn-2 are required in neurons, 
but not body-wall muscles, to maintain 
neuronal positioning
We previously showed that sax-7 is required in neurons as well 
as the adjacent hypodermis and body-wall muscles for positional 
Figure  1.  dys-1  and  stn-2  are  required  in 
body-wall muscles, but not neurons, to regu-
late locomotion behavior. (A) Quantification of 
young adult animals that exhibit exaggerated 
head bending during locomotion. Two sample 
sets were analyzed for wild type (WT), dys-1, 
and stn-2, in which n = 50 for each set. This 
phenotype  is  suppressed  in  dys-1  and  stn-2 
animals when the respective gene is expressed 
in the muscle (driven by the myo-3 promoter) 
but not in neurons (driven by the unc-119 pro-
moter).  Three  independent  transgenic  lines 
were analyzed for each construct. The error 
bar of each transgenic line shows the standard 
error of the proportions of four sample sets in 
which n = 50 in each set. (B) Quantification of 
body bends per minute for the different strains 
(see Materials and methods). Three indepen-
dent transgenic lines were analyzed for each 
construct.  The  error  bars  show  the  standard 
error  of  proportions  of  four  sample  sets  in 
which n = 15 in each sample set. Statistical 
significance was assessed by Student’s t test as 
compared with wild-type animals.JCB • VOLUME 192 • NUMBER 2 • 2011   352
Figure  2.  Mutations  in  dys-1  cause  defects 
in maintaining neuronal positions. (A and B) 
Schematics  and  corresponding  micrographs 
of VNC cholinergic neurons, as visualized in 
a young adult wild-type (WT) and dys-1(cx18) 
animal expressing the Punc-129::gfp marker (A)   
and VNC GABA neurons, as visualized in a 
young  adult  wild-type  and  a  dys-1(cx18)/
+;sax-7(eq1)/+  animal  expressing  UNC-47::
GFP  (B).  The  brackets  in  A  mark  the  vulval 
muscles, which also express unc-129::gfp. The 
green  dots  and  lines  represent  the  neuronal 
cell bodies and axonal processes, respectively. 
(C–E) The cholinergic neurons DB5, DA5, and 
DB6 and GABA neurons VD11, VD12, DD6, 
and  VD13  are  stereotypically  positioned  in 
wild-type animals (see Materials and methods; 
Fig. S4). The relative positions of the choliner-
gic neurons are altered in >20% dys-1 adult 
animals, a phenotype that is less prevalent in 
dys-1 larvae (C), suggesting a positional main-
tenance  role  for  dys-1.  The  quantification  of 
young adult animals exhibiting displaced cho-
linergic (D) and GABA (E) neurons in dys-1 and 
sax-7 mutant backgrounds reveals a genetic 
interaction between dys-1 and sax-7. Error bars 
show the standard error of the proportions of 
three sample sets in which n = 100 in each 
set. The p-values in C–E show the statistical sig-
nificance as assessed by the Z test between the 
indicated strains. Bars, 10 µm.353 DYS-1/dystrophin maintains neural integrity • Zhou and Chen
both  dys-1  and  stn-2  are  required  in  neurons  to  maintain   
neuronal positioning, a function that is independent of their 
role in body-wall muscles.
STN-2 interacts with DYS-1 by yeast  
two-hybrid (Y2H) assays
Vertebrate syntrophins, including -syntrophins, can bind dys-
trophins via their C-terminal syntrophin unique (SU) region 
(Ahn and Kunkel, 1995; Ahn et al., 1996; Castelló et al., 1996). 
The 62–amino acid SU region of STN-2 shares 55 and 62% 
similarity with the SU region of human 1- and 2-syntrophin, 
respectively. This conservation of the SU region in STN-2 indi-
cates a possible interaction between STN-2 and DYS-1.
To investigate whether STN-2 interacts with DYS-1, a 
Y2H assay was performed. In this assay, rather than using full-
length DYS-1, which is predicted to be a 417-kD protein, we 
tested the DYS-1 C-terminal end, which contains homol-
ogous sequences to mammalian dystrophins that are required 
for interacting with syntrophins (Bessou et al., 1998; Gieseler   
et al., 1999a). Yeast transformed with the full-length stn-2 and   
C-terminal dys-1 clones showed robust cell growth on the L/T/H 
and L/T/H/A selective media, indicating a positive interaction 
between STN-2 and DYS-1 (Fig. 5 A). An interaction between 
STN-1/-syntrophin and DYS-1 was assessed as a negative 
control. As expected, STN-1/-syntrophin and DYS-1 did not 
interact (Fig. 5 B), which was similar to results of a previous 
Y2H assay (Grisoni et al., 2003). We also did not observe an inter-
action between STN-2 and the dystrophin-like molecule DYB-1/
dystrobrevin (Fig. 5 C). To determine that the negative controls 
STN-1 and DYB-1 were expressed and functional in the Y2H 
indicating that the expressed DYS-1/dystrophin in muscles   
is functional. In fact, transgenic dys-1 animals that expressed 
DYS-1/dystrophin in body-wall muscles are indistinguishable 
from wild-type animals, exhibiting no obvious phenotype other 
than displaced neurons. In contrast, dys-1 animals expressing 
DYS-1/dystrophin in neurons still displayed the characteristic 
locomotory and head-bending phenotype (Fig. 1). This result   
is consistent with a previous study that revealed a requirement 
for DYS-1 in muscles, but not in neurons, for wild-type move-
ments (Bessou et al., 1998). Thus, dys-1 has two separable 
roles; i.e., dys-1 functions in neurons to maintain neuronal   
positioning and acts in body-wall muscles to control locomo-
tory behavior.
stn-2 is also expressed in VNC motor neurons and body-
wall muscles (Zhou et al., 2008). Because dys-1 is required 
only in neurons to maintain neuronal positioning, we antici-
pated that stn-2 would also be required in neurons, but not 
muscles,  for  this  function.  Indeed,  neuronal  expression  of 
STN-2/-syntrophin rescues the displaced VNC cholinergic 
and GABA neurons in stn-2/+ animals in either sax-7(eq1)/+ 
or a homozygous sax-7(eq2) sensitized background (Fig. 4). 
In contrast, muscle expression of STN-2/-syntrophin failed 
to rescue the neuronal displacement (Fig. 4). Like dys-1, ex-
pression of STN-2/-syntrophin in muscles, but not in neu-
rons,  rescues  the  abnormal  locomotion  and  head  bending 
exhibited by stn-2 animals (Fig. 1). Similar to dys-1, both 
stn-2 animals and stn-2/+ animals in either a sax-7(eq1)/+ or 
a homozygous sax-7(eq2) sensitized background do not exhibit 
muscle degeneration or obvious muscle abnormalities (Fig. S1), 
which may indirectly cause displacement of neurons. Thus, 
Figure 3.  dys-1 is required in neurons, but not muscle, to maintain neuronal position. (A and B) Tissue-specific expression assays reveal that dys-1 func-
tions in neurons, but not body-wall muscles, to maintain the position of cholinergic (A) and GABA (B) neurons. Neuronal and muscle expressions of dys-1 
were driven by the unc-119 and myo-3 promoters, respectively. Three independent transgenic lines were analyzed for each construct. The error bars show 
the standard error of the proportions of three sample sets in which n = 100 in each set. Statistical significance was assessed by the Z test. WT, wild type.JCB • VOLUME 192 • NUMBER 2 • 2011   354
of STN-2 to the cell cortex where the neurofascin::SAX-7 chi-
mera is localized (Fig. 6 B). This result is consistent with the 
previously described interaction of STN-2/-syntrophin with 
the SAX-7CT (Zhou et al., 2008). If STN-2/-syntrophin func-
tions as an adaptor to link SAX-7 to DYS-1/dystrophin, SAX-7 
should similarly recruit DYS-1/dystrophin to the cell cortex in 
an STN-2/-syntrophin–dependent manner. To test this predic-
tion,  HEK293T  cells  were  transfected  with  dys-1::myc  and 
neurofascin::sax-7  clones. As  with  the Y2H  assay,  the  dys-
1::myc clone encodes only the DYS-1 C-terminal region, which 
carries the syntrophin-interacting domain. DYS-1::Myc is cyto-
plasmic and does not colocalize with neurofascin::SAX-7 at the 
plasma membrane (Fig. 6 C). However, when FLAG::STN-2 is co-
expressed together with DYS-1::Myc and neurofascin::SAX-7, 
DYS-1::Myc is largely redistributed from the cytoplasm to 
the cell cortex (Fig. 6 D). These results strongly suggest that 
DYS-1/dystrophin associates with SAX-7 only when STN-2/ 
-syntrophin is present.
To  further  confirm  that  DYS-1/dystrophin  and  STN-2/ 
-syntrophin form a complex with SAX-7, the biochemical inter-
actions of the three proteins were tested in HEK293T cells via 
coimmunoprecipitation (IP [co-IP]) assays. Neurofascin::SAX-7 
was detected in anti-FLAG IPs of HEK293T cell lysates con-
taining FLAG::STN-2 and neurofascin::SAX-7 (Fig. 7, A [lane 2] 
and B [lane 1]). In contrast, neurofascin::SAX-7 was not detected 
assays, a known interaction between them (Grisoni et al., 2003) 
was tested, which was positive as expected (Fig. 5 D). These 
negative controls underscore the specificity of the interaction 
between STN-2 and DYS-1. Thus, the two C. elegans syntrophins 
differentially interact with the dystrophin family of proteins; 
STN-2/-syntrophin interacts specifically with DYS-1/dystrophin, 
whereas STN-1/-syntrophin interacts with DYB-1/dystrobrevin. 
Consistent  with  these  molecular  interactions,  STN-1/-
syntrophin and DYB-1/dystrobrevin do not participate in neu-
ronal positional maintenance (Fig. S3; Zhou et al., 2008).
STN-2 acts as an adaptor to link SAX-7 to 
the DYS-1 cytoskeleton
STN-2/-syntrophin can interact with both SAX-7 (Zhou et al., 
2008) and DYS-1/dystrophin (Fig. 5 A), which was consistent 
with our hypothesis that STN-2/-syntrophin couples SAX-7 to 
DYS-1/dystrophin. To further test this hypothesis, we performed 
a protein recruitment assay using cultured cells, which was pre-
viously  used  to  evaluate  interactions  between  ankyrin  and 
L1CAMs (Zhang et al., 1998; Chen et al., 2001; Zhou et al., 
2008). FLAG::STN-2 is primarily localized in the cytoplasm 
when expressed in HEK293 cells (Fig. 6 A). However, cotrans-
fection with a SAX-7 construct, which is composed of rat neuro-
fascin extracellular and transmembrane domains fused to the 
SAX-7 cytoplasmic tail (SAX-7CT), results in the redistribution 
Figure 4.  stn-2 is required in neurons, but not muscle, to maintain neuronal position. (A–D) Tissue-specific expression assays reveal that stn-2 functions in 
neurons, but not body-wall muscles, to maintain the position of cholinergic (A and B) and GABA (C and D) neurons. Moreover, this function requires the 
STN-2 PDZ domain. Three independent transgenic lines were analyzed for each construct in which neuronal and muscle expressions of STN-2 were driven 
by the unc-119 and myo-3 promoters, respectively. The error bars show the standard error of the proportions of three sample sets in which n = 100 in each 
set. Statistical significance was assessed by the Z test. WT, wild type.355 DYS-1/dystrophin maintains neural integrity • Zhou and Chen
suggested otherwise (Gieseler et al., 1999a). This difference 
may reflect dissimilar experimental approaches and conditions that 
could suggest a weak interaction between STN-1/-syntrophin 
and DYS-1/dystrophin. For example, the intrinsic ability for 
GST to dimerize (Walker et al., 1993; Dirr et al., 1994; Lim 
et al., 1994) could have resulted in the oligomerization of the 
GST–STN-1 fusion protein that was used in the in vitro binding 
assay, which, in turn, may have enhanced a weak interaction 
between STN-1 and DYS-1. Similar oligomerization and influ-
ence of activity on diverse fusion proteins induced by GST have 
been reported (Haldeman et al., 1997; Mernagh et al., 1997; 
Niedziela-Majka et al., 1998).
To investigate whether SAX-7 could interact with DYS-1/
dystrophin, anti-Myc IPs were performed on cell lysates con-
taining both DYS-1::Myc and neurofascin::SAX-7. Neurofas-
cin::SAX-7 did not coimmunoprecipitate (Fig. 7, E [lane 2] and 
F [lane 3]), which was consistent with a lack of association   
between SAX-7 and DYS-1/dystrophin, as suggested in the 
protein recruitment assay. However, in anti-Myc IPs on lysates 
of cells in which FLAG::STN-2 was cotransfected with both   
DYS-1::Myc  and  neurofascin::SAX-7CT,  neurofascin::SAX-
7CT coimmunoprecipitated along with FLAG::STN-2 (Fig. 7, 
E and F, lanes 1), which was consistent with SAX-7 being pres-
ent in a complex with DYS-1 and STN-2. Collectively, these   
in anti-FLAG IPs on cell lysates containing FLAG::STN-1 and 
neurofascin::SAX-7 (Fig. 7 A, lane 5) or FLAG::STN-2 and 
neurofascin::SAX-7CT lacking the PB sequence (Fig. 7 A, lane 4). 
These results were expected based on our previous results 
that STN-2/-syntrophin, but not STN-1/-syntrophin, inter-
acts with SAX-7 via the PB domain (Zhou et al., 2008). Neuro-
fascin::SAX-7  was  also  not  detected  in  IPs  of  cell  lysates 
containing a mutated FLAG::STN-2 that lacks the PDZ domain 
(STN-2::PDZ) and neurofascin::SAX-7 (Fig. 7 B, lane 2), sug-
gesting that the PDZ domain is required for STN-2/-syntrophin 
to interact with SAX-7. The importance of the STN-2 PDZ do-
main is underscored by the result that expression of STN-2::PDZ 
cannot rescue the neuronal displacement phenotype in sax-
7(eq1)/+;stn-2/+ animals or suppress the phenotypic enhance-
ment in sax-7(eq2)/sax-7(eq2);stn-2/+ animals (Fig. 4).
The interaction between STN-2/-syntrophin and DYS-1/
dystrophin was tested next. Reciprocal co-IPs were observed 
with FLAG::STN-2 and DYS-1::Myc (Fig. 7, C and D, lane 2) 
but not with FLAG::STN-1 and DYS-1::Myc (Fig. 7, C and D, 
lane 4). It is interesting that both our Y2H and co-IP experiments, 
as well as an independent Y2H assay (Grisoni et al., 2003), consis-
tently showed a lack of interaction between STN-1/-syntrophin 
and the C-terminal end of DYS-1, whereas a previously published 
in vitro binding assay using a purified GST–STN-1 fusion protein 
Figure  5.  STN-2,  but  not  STN-1,  molecularly  interacts 
with DYS-1, as determined by Y2H assays. The prey is 
comprised of full-length STN-2 or STN-1, whereas the bait 
is comprised of the C terminus of DYS-1 (amino acid resi-
dues 3,402–3,674) or full-length DYB-1. Cell growth on 
L/T selective media shows yeast cells that are successfully 
transformed with both the prey and bait constructs. Cell 
growth on L/T/H or L/T/H/A selective media reveals pos-
itive interactions between STN-2 and DYS-1 and between 
STN-1 and DYB-1.JCB • VOLUME 192 • NUMBER 2 • 2011   356
A distinct neuronal DPC functions to 
maintain neural architecture
Mutations in dys-1 cause progressive muscle degeneration in 
sensitized genetic backgrounds (Gieseler et al., 2000; Mariol   
et al., 2007), indicating a conserved role for dystrophin in main-
taining muscle integrity. dys-1 mutant animals also exhibit a 
distinctive movement phenotype (i.e., exaggerated bending of 
the head and anterior body and prolonged muscle contraction), 
which is shown, in part, to be caused by abnormal cholinergic 
transmission (Bessou et al., 1998; Giugia et al., 1999). This 
phenotype can be rescued by wild-type DYS-1 expressed in mus-
cle but not neurons (Bessou et al., 1998). Mutations in genes 
encoding other components of the C. elegans DPC, such as 
stn-2/-syntrophin, stn-1/-syntrophin, and dyb-1/dystrobrevin, 
also lead to locomotory phenotypes that are indistinguish-
able from that of dys-1, suggesting that these DPC compo-
nents function in muscles for proper cholinergic transmission 
results strongly suggest a role for STN-2/-syntrophin as an 
adaptor protein that couples SAX-7 and DYS-1/dystrophin to-
gether in a protein complex.
Discussion
This study uncovers a novel neuronal role for DYS-1/dystrophin 
in maintaining the structure and organization of the C. elegans 
nervous system in collaboration with the SAX-7/L1CAM. This 
role is distinct from its previously established muscle function 
in maintaining muscle integrity and regulating locomotion. The 
presented genetic and biochemical data provide evidence that 
SAX-7 is linked to DYS-1/dystrophin via STN-2/-syntrophin and 
that this tripartite protein complex is required in neurons (Fig. 8). 
Dystrophin and the associated actin cytoskeleton likely provide 
anchorage to SAX-7, thereby regulating SAX-7 activity in main-
taining neuronal positions.
Figure 6.  Protein recruitment assays in HEK293 cells suggest that SAX-7 associates with DYS-1 only in the presence of STN-2. (A) FLAG::STN-2 is primar-
ily localized in the cytoplasm, as detected by immunostaining with an anti-FLAG antibody. (B) Cotransfection with neurofascin::SAX-7CT (labeled SAX-7) 
causes FLAG::STN-2 to be redistributed to the cell cortex where SAX-7 is localized. (C) DYS-1::Myc, which contains the DYS-1 C-terminal amino acid 
residues 3,402–3,674, is primarily localized in the cytoplasm, as detected by anti-Myc antibody in cells transfected with both DYS-1::Myc and 
neurofascin::SAX-7CT. (D) When STN-2 is cotransfected, DYS-1::Myc is redistributed to the cell cortex where SAX-7 is localized, thus suggesting that SAX-7 
can associate with DYS-1 via STN-2. Bar, 15 µm.357 DYS-1/dystrophin maintains neural integrity • Zhou and Chen
(Fig. S3; Zhou et al., 2008), although both proteins are also ex-
tensively expressed in the nervous system (Gieseler et al., 2001; 
Grisoni et al., 2003). It is not known what function STN-1/-
syntrophin or DYB-1/dystrobrevin mediates in neurons or whether 
these roles involve DYS-1/dystrophin. Thus, at least in neurons, 
the DPCs are likely variable in composition and function.
It is not clear how neuronal displacement impacts neu-
ral functions in dys-1 mutant animals or whether dys-1 me-
diates additional functions in neurons other than maintaining 
(Fig. 1; Gieseler et al., 1999b, 2001; Grisoni et al., 2003; Kim   
et al., 2004). Indeed, stn-1 and stn-2 expression in muscles, but 
not neurons, can rescue the locomotory phenotype in the re-
spective mutant animals (Fig. 1; Grisoni et al., 2003).
In addition to a role for the DPC in muscles, we identi-
fied a novel neuronal role of DYS-1/dystrophin and STN-2/ 
-syntrophin in the positional maintenance of neurons, which is 
independent of their function in muscles. This neuronal role is 
not  shared  by  STN-1/-syntrophin  or  DYB-1/dystrobrevin 
Figure 7.  STN-2 acts as a linker protein that bridges SAX-7 to DYS-1, as determined by co-IP assays in HEK293 cells. (A and B) Neurofascin::SAX-7CT (labeled 
SAX-7) interacts with STN-2, as shown in A (lane 2) and B (lane 1). This interaction depends on the SAX-7 PB sequence (A, lane 4) and the STN-2 PDZ domain 
(B, lane 2). This interaction between SAX-7 and STN-2 is specific because SAX-7 does not interact with STN-1 (A, lane 5). (C and D) The C-terminal end of 
DYS-1 (amino acid residues 3,402–3,674) interacts with STN-2, but not STN-1, as DYS-1 coimmunoprecipitates with STN-2 (C, lane 2) but not with STN-1 (C, 
lane 4). The reverse IP shows that STN-2 (D, lane 2), but not STN-1 (D, lane 4), coimmunoprecipitates with DYS-1. (E and F) Although SAX-7 does not coimmuno-
precipitate with DYS-1 (E, lane 2; and F, lane 3), SAX-7 does so when STN-2 is present (E, lane 1; and F, lane 1), suggesting this tripartite complex requires 
STN-2 as a linking molecule. Co-IP of SAX-7 with STN-2 and DYS-1 requires the PB sequence of SAX-7 (E, lane 3) and the PDZ domain of STN-2 (F, lane 2).JCB • VOLUME 192 • NUMBER 2 • 2011   358
of  linkage  to  the  spectrin-actin  cytoskeleton  (Zhou  et  al., 
2008). We thus speculate that STN-2/-syntrophin and DYS-1/ 
dystrophin participate in neuronal positional maintenance by 
coupling SAX-7 to the cortical actin cytoskeleton. Interruption 
of this cytoskeleton linkage by either deletion of the SAX-7 PB 
sequence or the STN-2 PDZ domain or by knocking out stn-2  
or dys-1 function leads to defects in maintaining neuronal 
position, probably caused by reduced SAX-7 activity in mediat-
ing cell adhesion.
It is thus puzzling that displaced cholinergic neurons are 
detected in dys-1, but not in stn-2, mutant animals. This differ-
ence suggests that DYS-1/dystrophin can also mediate SAX-7 
function in an STN-2–independent fashion. Proteins that may 
compensate for the loss of STN-2/-syntrophin are not known, 
but one candidate protein may be UNC-44/ankyrin. A recent 
study uncovered the ability of mammalian ankyrins to bind dys-
trophin via a cysteine-rich domain, which is located close to, 
but distinct from, the syntrophin-interacting domain in the   
C terminus of dystrophin (Ayalon et al., 2008). Interaction with 
dystrophin has been shown for ankyrin-G and ankyrin-B, which 
are required for the proper localization of dystrophin at the 
costameres and sarcolemma, respectively, in murine skeletal 
muscle (Ayalon et al., 2008). Thus, UNC-44/ankyrin may 
neuronal positioning. Animals that lack dys-1 in neurons (i.e., 
dys-1 mutant animals expressing dys-1 only in muscles) have no 
obvious phenotype other than displaced neurons. Assays that as-
sess behavior and higher order neural function (e.g., learning and 
memory) still need to be performed to address these questions.
STN-2/-syntrophin and DYS-1/dytrophin 
provide cytoskeletal anchorage to SAX-7
The protein recruitment assay and co-IP experiments suggest 
that STN-2/-syntrophin can act as an adaptor to link SAX-7 to 
DYS-1/dystrophin. As dystrophin is an actin-binding protein, 
the  association  of  SAX-7  with  DYS-1/dystrophin  raises  the 
possibility that SAX-7 is linked to the cortical actin cytoskele-
ton. Linkage of CAMs, including L1CAMs, cadherins, and in-
tegrins, to the cortical cytoskeleton has been shown to be 
required for robust cell adhesion (Bökel and Brown, 2002;   
Nagaraj  and  Hortsch,  2006;  Hartsock  and  Nelson,  2008).   
Indeed, cultured cells expressing neurofascin that cannot bind 
ankyrin exhibit reduced cell–cell adhesion, presumably because 
of a poor association with the spectrin-based actin cytoskeleton 
(Garver et al., 1997; Tuvia et al., 1997). In C. elegans, UNC-44/
ankyrin has been shown to function with SAX-7 in neuronal 
positional maintenance, which was consistent with the importance 
Figure 8.  A model depicting how STN-2/-syntrophin may regulate SAX-7 activity in maintaining neuronal positions, as based on genetic and biochemi-
cal data. The model speculates that STN-2/-syntrophin links SAX-7 to the DYS-1/dystrophin-based actin cytoskeleton in neurons but not muscles. This inter-
action is dependent on the STN-2 PDZ domain to interact with the SAX-7 PB motif and requires the STN-2 syntrophin unique (SU) domain to interact with the 
C-terminal end of DYS-1. DYS-1 is predicted to bind to the actin cytoskeleton by its N-terminal actin-binding domain. This linkage to the actin cytoskeleton 
may provide SAX-7 anchorage, thereby regulating SAX-7–mediated cell adhesion. Interruption of this anchorage leads to a defect in maintaining neuronal 
positions. UNC-44/ankyrin also interacts molecularly and genetically with SAX-7 (Zhou et al., 2008), but it is not known whether UNC-44/ankyrin is re-
quired in neurons and/or body-wall muscles; this unknown is depicted as “UNC-44?” in the schematic. Ig, Ig-like repeats; FNIII, fibronectin type III repeats; 
FB, FERM-binding sequence; and AB, ankyrin-binding sequence.359 DYS-1/dystrophin maintains neural integrity • Zhou and Chen
for some of the functional and architectural abnormalities pres-
ent in the brains of DMD patients and mdx mice.
The  association  of  DYS-1/dystrophin  with  SAX-7  via 
STN-2  suggests  that  mammalian  L1CAMs  could  similarly 
function with dystrophin in the nervous system. Of the mam-
malian  L1CAMs,  NrCAM  has  a  PB  sequence  (amino  acids 
NSFV) that is most similar to that of SAX-7 (amino acids 
STFV). The similar expressions of NrCAM, -syntrophins, and 
dystrophin in the cerebral cortex, hippocampal pyramidal neu-
rons, and the cerebellar cortex Purkinje cells of the mammalian 
brain are consistent with their ability to interact (Lidov et al., 
1993; Piluso et al., 2000; Hogan et al., 2001; Backer et al., 2002; 
Alessi et al., 2006; Ishiguro et al., 2006; Heyden et al., 2008; 
Minciacchi  et  al.,  2010). Although  it  is  not  known  whether 
NrCAM functions in a similar capacity as SAX-7 for proper 
neural organization, the importance of NrCAM in the brain is 
underscored by the impaired cognitive function and social   
behavior exhibited by NrCAM-null mice (Moy et al., 2009). 
Moreover,  mutations  in  human  NrCAM  can  lead  to  autism 
(Marui et al., 2009), a disorder that is also presented in signifi-
cant numbers of DMD patients (Wu et al., 2005; Hendriksen 
and Vles, 2008). The apparent overlap of neural symptoms of 
DMD  and  L1CAM  disorders,  together  with  our  data  that 
DYS-1/dystrophin and SAX-7 function in a complex, suggests 
the mammalian counterparts may act in a homologous fashion 
for proper neural architecture and nervous system function.
Materials and methods
Strains
C. elegans strains, provided by the Caenorhabditis Genetics Center, were 
grown  on  nematode  growth  medium  plates  at  21°C  as  described  by 
Brenner (1974). N2 Bristol served as the wild-type strain. The alleles used 
in this study are listed by linkage groups as follows: LGI, dys-1(cx18),   
dys-1(cx40) (Bessou et al., 1998), and dyb-1(cx36) (Gieseler et al., 1999b); 
LGIV, sax-7(eq1) (Zhou et al., 2008), and sax-7(eq2) (Wang et al., 2005); 
and LGX and stn-2(tm1869) (Zhou et al., 2008).
C. elegans expression vectors and generation of transgenic animals
Transgenic  animals  were  generated  according  to  standard  procedures 
(Mello et al., 1991). To generate Punc-119::dys-1 (pLC587), a 9.0-kb dys-1 
genomic sequence from WRM0611bE10 (Geneservice) was pieced to-
gether at exon 30 with 3.9-kb dys-1 cDNA and 169-bp dys-1 3 untrans-
lated region (obtained from yk1473g12 and yk1434h02; Y. Kohara, 
National Institute of Genetics, Mishima, Japan) and subcloned into the 
pBluescript II KS vector between NotI and XmaI. The pan-neuronal unc-119 
promoter (Maduro and Pilgrim, 1995, Maduro et al., 2000) was inserted 
at NotI to drive dys-1 expression in neurons. The resulting construct was 
injected at 190 ng/µl along with 2 ng/µl of the coinjection marker   
Pmyo-2::tdTomato (a gift from S. Panowski and A. Dillin, Salk Institute,   
La Jolla, CA) into dys-1(cx18).
To generate Pmyo-3::dys-1 (pLC586), a pLC587 derivative replacing 
the unc-119 promoter with the muscle-specific myo-3 promoter (Fire et al., 
1998) was used to drive dys-1 expression in muscles. 160 ng/µl of the re-
sulting construct was injected into dys-1(cx18) along with 40 ng/µl of the 
coinjection marker sur-5::dsRed (Yochem et al., 1998).
To generate Pstn-2::stn-2::gfp (pLC551), the stn-2 promoter (3.82-kb 
sequences upstream of the start codon) and 1.5-kb stn-2 cDNA (obtained 
from yk788e09; Y. Kohara) were placed in frame with gfp coding se-
quences and the unc-54 3 untranslated region (Fire et al., 1990), all of 
which were subcloned into the pBluescript II KS vector between NotI and 
ApaI. 50 ng/µl of the resulting construct was injected into stn-2(tm1869) 
animals  along  with  50  ng/µl  of  the  coinjection  marker  sur-5::dsRed  
(Yochem et al., 1998).
To generate Punc-119::stn-2::gfp (pLC553), a pLC551 derivative with 
the stn-2 promoter was replaced with the unc-119 promoter. 50 ng/µl of 
compensate for the loss of STN-2 to couple SAX-7 to the 
dystrophin-based cytoskeleton, thus reflecting the lack of pheno-
type in stn-2 mutant animals. This speculation would require 
that the regulation of SAX-7 activity by UNC-44/ankyrin occurs 
in neurons, which is currently not known.
The expression of UNC-44/ankyrin in neurons, body-wall 
muscles, and the hypodermis (Chen et al., 2001) suggests that 
UNC-44/ankyrin could regulate SAX-7 activity in one or more 
of these tissues; SAX-7 is required in all three tissues to ensure 
that neural integrity is maintained (Wang et al., 2005). Consis-
tent with UNC-44/ankyrin acting as an adaptor to link SAX-7   
to  the  spectrin-actin  cytoskeleton,  SPC-1/-spectrin  and 
UNC-70/-spectrin are similarly expressed in multiple tissues, 
including  neurons,  body-wall  muscles,  and  the  hypodermis 
(Hammarlund et al., 2000; Moorthy et al., 2000; Norman and 
Moerman, 2002). That SAX-7 may be coupled to both the 
dystrophin- and spectrin-based actin cytoskeletons raises the   
question of how cytoskeletal linkage of SAX-7 is coordinated. 
Are both the dystrophin- and spectrin-based cytoskeletons   
required in neurons for SAX-7 activity? Is SAX-7 associated 
with both cytoskeletons simultaneously, or are distinct sub-
populations of SAX-7 linked to each cytoskeleton? If only 
the dystrophin-based cytoskeleton is required in neurons, how 
is linkage to the spectrin-based cytoskeleton prevented? In addi-
tion to the cortical actin cytoskeleton, dystrophin also binds   
intermediate filaments and microtubules (Prins et al., 2009;   
Le Rumeur et al., 2010). Thus, SAX-7 may be simultaneously 
anchored to one of these alternative cytoskeletons in addition to 
the spectrin-actin cytoskeleton.
Implications for mammalian L1CAMs
Mammalian  dystrophin  and  DPC  components  are  also  ex-
pressed in neurons (Waite et al., 2009). In contrast to their func-
tions in muscles, dystrophin and the DPC components in the 
mammalian nervous system have not been as extensively char-
acterized. These neuronal DPC complexes apparently are mo-
lecularly heterogeneous (Blake and Kröger, 2000; Waite et al., 
2009), suggesting multiple neuronal roles for the DPC.
The importance of dystrophin in the brain is directly indi-
cated by cognitive impairments and neuropsychiatric disorders 
(e.g., autism and schizophrenia) that can be presented in DMD 
patients (Bresolin et al., 1994; Anderson et al., 2002). Autopsy 
studies on DMD patients revealed brain abnormalities that   
include  disordered  connections  and  architectural  changes 
(Rosman, 1970; Jagadha and Becker, 1988; Moriuchi et al., 
1993; Uchino et al., 1994; Kim et al., 1995). The mdx dystro-
phin mutant mice similarly exhibit an abnormal architecture of 
the brain that includes altered distribution of populations of 
neurons (Carretta et al., 2004; Del Tongo et al., 2009; Minciacchi 
et al., 2010). They also display altered spontaneous inhibitory 
postsynaptic  currents  in  the  cerebellar  Purkinje  cells,  which 
may reflect the need for dystrophin to cluster GABAA receptors 
in hippocampal pyramidal neurons and inhibitory synapses of 
cerebellar Purkinje cells (Knuesel et al., 1999; Anderson et al., 
2003; Kueh et al., 2008). Based on the role of C. elegans dystro-
phin in maintaining neural organization, impaired mammalian 
dystrophin may similarly affect neural integrity, thus accounting JCB • VOLUME 192 • NUMBER 2 • 2011   360
and pLC570, respectively contain stn-1 and stn-2 cDNA, which were sub-
cloned into the pGBKT7 vector (Trp selective marker) in frame with the 
GAL4 DNA-binding domain. The preys, pLC571 and pLC572, respectively 
contain a dys-1 cDNA fragment encoding amino acids 3,402–3,674 and 
dyb-1 cDNA, which were subcloned into the pGADT7 vector (Leu selective 
marker) in frame with the GAL4 DNA-activating domain.
Y2H assays
All yeast assays were performed in the AH109 yeast strain, which were 
cultured on the following synthetic defined (SD) minimal media lacking 
specified  amino  acids  according  to  the  manufacturer’s  instructions:   
SD/Leu, SD/Trp, SD/Leu/Trp, SD/Leu/Trp/His + 2.5 mM 
3-AT,  SD/Leu/Trp/His/Ade  +  12.5  mM  3-AT,  SD/Leu/His  +   
2.5  mM  3-AT,  and  SD/Trp/His  +  2.5  mM  3-AT  (Takara  Bio  Inc.).   
2.5 mM 3-AT was added to reduce the number of background colonies 
caused by leaky His expression. We confirmed that both bait and prey 
constructs (a) did not activate readout reporters on their own, e.g., grow 
on media lacking His or His/Ade, and (b) did not interact nonspecifically 
with the provided negative control pGADT7-T (for baits) or pGBKT7-lam 
(for preys). A positive interaction was considered robust if there were   
numerous large nonred (white) colonies growing on media lacking Leu/
Trp/His/Ade.  Positive  interactions  were  further  assayed  by  performing   
X-- and -galactosidase tests on these nonred colonies, which should turn 
strongly blue if there is robust interaction between bait and prey.
Mammalian cell expression vectors
Mammalian cell expression vectors used in this study were neurofascin::
SAX-7CT (pLC101; Chen et al., 2001); neurofascin::SAX-7::PB (pLC573), 
a pLC101 derivative lacking the PB motif STFV; Pcmv::FLAG::stn-1 (pLC565), 
the  stn-1  cDNA  (obtained  from  yk109h11)  that  was  subcloned  into 
p3×FLAG-CMV-7.1 (Sigma-Aldrich) between NotI and KpnI; Pcmv::FLAG::
stn-2 (pLC566), the stn-2 cDNA that was subcloned into p3×FLAG-CMV-
7.1 (Sigma-Aldrich) between SalI and BamHI; and Pcmv::FLAG::stn-2::PDZ 
(pLC588), a pLC566 derivative lacking the PDZ domain (amino acids 74–
150). Pcmv::dys-1::Myc (pLC574), a dys-1 cDNA fragment encoding amino 
acids 3,402–3,674, was cloned into pcDNA3.1/Myc–His B (Invitrogen) 
between KpnI and BamHI.
Cell culture and transfection
HEK293T cells were cultured in DME (Mediatech, Inc.) with 10% newborn 
bovine serum and treated with transfection reagent (Lipofectamine 2000; 
Invitrogen) according to the standard procedure provided by the manufac-
turer during DNA transfection. 40 h after transfection, cells were collected 
and washed with PBS in preparation for either immunofluorescence or   
co-IP assays.
Protein recruitment assay in HEK293 cells
The assay was performed as previously described (Zhang et al., 1998). 
Cells were fixed with formaldehyde, washed, and incubated with anti-FLAG 
(M2;  Sigma-Aldrich),  anti-Myc  (9E10;  Covance),  or  anti-SAX-7  (6991; 
Chen et al., 2001) antibodies to visualize FLAG::STN-2, DYS-1::Myc, or 
neurofascin::SAX-7CT, respectively. Images were acquired using Axioplan 
2 IE, AxioCam MRm, and AxioVision 4.5.
Co-IP assays
Cell lysates were prepared in NETN buffer containing 1 mM NaF, 2.5 mM 
-glycerophosphate, and a protease inhibitor cocktail (Roche). 200–500 
µl of cell lysate was incubated with NETN buffer (0.05-M Tris, pH 7.8, 
0.1-M NaCl, 1 mM EDTA, and 0.5% NP-40) containing the FLAG or Myc 
antibody at 4°C for 1 h. Immune complexes were precipitated with 20 µl 
of protein A/G beads (Santa Cruz Biotechnology, Inc.) at 4°C for 4 h. The 
beads were washed three times with NETN lysis buffer, and then the im-
mune complexes were eluted by heating the beads to 95°C for 5 min in 
SDS sample buffer containing DTT. Blots were probed as described in the 
next section.
Western blot analysis and reagents
Cell lysates were prepared in NETN buffer containing 1 mM NaF, 2.5 mM 
-glycerophosphate, and a protease inhibitor cocktail. Cell lysates were 
resolved by SDS-PAGE and electrophoretically transferred to the nitrocellu-
lose membrane. Membranes were blocked in TBS-T (0.15-M NaCl, 20 mM 
Tris, pH 8, and 0.05% Tween 20) containing 5% bovine albumin (Sigma-
Aldrich) for 1 h. Blots were probed with primary antibodies followed by 
horseradish  peroxidase–conjugated  anti–mouse  (Mouse  TrueBlot  Ulture; 
eBioscience) or anti–rabbit secondary antibody (Jackson ImmunoResearch 
this construct was injected into stn-2(tm1869) animals along with 70 ng/µl 
of the coinjection marker Pstr-1::gfp (Troemel et al., 1995). Punc-119::stn-2::
gfp::PDZ (pLC590) was generated from a pLC553 derivative lacking the 
STN-2 PDZ domain (amino acids 74–150), which was injected at 50 ng/µl 
into stn-2(tm1869) animals along with 70 ng/µl of the coinjection marker 
Pstr-1::gfp (Troemel et al., 1995).
Pmyo-3::stn-2::gfp (pLC554) was generated from a pLC553 derivative 
that replaced the stn-2 promoter with the myo-3 promoter. This construct 
was injected at 50 ng/µl into stn-2(tm1869) animals along with 70 ng/µl 
of the coinjection marker Pstr-1::gfp (Troemel et al., 1995).
Live animal microscopy—scoring for displaced neurons
The oxIs12 (unc-47::gfp; McIntire et al., 1997) and evIs78 (Punc-129::gfp; 
Colavita et al., 1998) integrated transgenes were crossed into respective 
strains to visualize GABA or cholinergic neurons, respectively. Synchro-
nized young adult animals of all these strains as well as synchronized dys-1  
larvae of various stages were mounted on 2% agarose pads and scored 
for neuronal displacement with the 40× 1.3 NA Neofluar objective using 
a microscope (Axioplan 2 IE) with the image captured with a camera   
(AxioCam MRm) and imaging software (AxioVision 4.5; Carl Zeiss, Inc.).
Of the VNC cholinergic neurons, the relative positions of the DB5, 
DA5, and DB6 neurons are most consistently altered in the examined ge-
netic strains as compared with wild type (Fig. 2 A) and, thus, were the 
focus of our analysis. The ratio of the distance between DB5 and DA5 
(designated D1) to the distance between DA5 and DB6 (designated D2) 
was calculated (Fig. S4 A). D1 and D2 are similar in wild-type animals so 
that the mean D1/D2 ratio is slightly more than one (Fig. S4 B). Neurons 
are considered displaced when the D1/D2 ratio in an animal is two or 
greater, as a result of the D2 value being less than half that of D1 because 
DA5 and DB6 are closer to each other (Fig. 2 A).
Of the VNC GABA neurons, the relative positions of VD11, VD12, 
DD6, and VD13 neurons are most consistently altered in the examined ge-
netic strains as compared with wild type (Fig. 2 B) and, thus, were the   
focus of our analysis. The ratio of the distance between VD11 and VD12 
(designated D1) to the distance between VD12 and VD13 (designated D2) 
was calculated (Fig. S4 C). In wild-type animals, D1 is generally more than 
three times larger than D2 so that the mean D1/D2 ratio is 3.5 (Fig. S4 D). 
Neurons are considered displaced when the D1/D2 ratio in an animal is 
one or less, as a result of the D1 value being equal to or less than that of 
D2 because VD12 or DD6 is closer to VD11 (Fig. 2 B).
Live animal microscopy—determining vulval position
Synchronized L4 wild-type, sax-7, and dys-1 animals were mounted on 2% 
agarose pads and were examined under a microscope (Axioplan 2 IE) to 
determine the position of the vulva relative to the pharynx and the anus. 
Based on the calculation PV/(PV + VA), in which PV is the distance   
between the base of the pharyngeal terminal bulb and the center of the 
vulva and VA is the distance between the center of the vulva and the anal 
opening (Fig. S3 A), the vulva in sax-7 and dys-1 animals appears to be 
positioned similarly to that of wild type (Fig. S3 B).
Locomotion assay
A single young adult animal (8–12 h after the L4 stage) was transferred to 
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